Trivolib 1 Tablet - Strip of 15

Prescription Required

Compositions : Glimepiride 1mg + Metformin 500mg + Voglibose 0.2mg

₹221.40 (Incl. GST)

MRP :

Out of stock

Delivery within 2 to 7 Working Days

Manufacture/Marketer: Sun Pharmaceutical Industries Ltd

Recommended Substitute

Trivolib 1 Tablet is a comprehensive pharmaceutical formulation designed specifically for the management of type 2 diabetes mellitus. This innovative medication combines three well-established anti-diabetic agents: Glimepiride, Metformin, and Voglibose, each contributing unique mechanisms of action to enhance blood glucose control. The primary purpose of Trivolib 1 Tablet is to improve glycemic control in patients whose diabetes is not adequately managed by diet and exercise alone. By addressing multiple metabolic defects that contribute to poor glycemic control, Trivolib 1 Tablet serves as an effective therapeutic option for individuals struggling with this chronic condition. The key composition of Trivolib 1 Tablet includes Glimepiride, a third-generation sulfonylurea that stimulates insulin secretion from functional pancreatic beta cells; Metformin, a biguanide that reduces hepatic glucose production and enhances insulin sensitivity; and Voglibose, an alpha-glucosidase inhibitor that delays carbohydrate absorption in the intestines. Together, these components work synergistically to target insulin secretion, insulin sensitivity, and carbohydrate absorption, making Trivolib 1 Tablet a powerful ally in diabetes management. The therapeutic category of Trivolib 1 Tablet encompasses its role as an anti-diabetic medication, specifically tailored for patients with type 2 diabetes who require more than just lifestyle modifications to achieve optimal blood sugar levels. With its unique formulation, Trivolib 1 Tablet not only helps in lowering fasting and postprandial blood glucose levels but also aids in stabilizing daily glucose fluctuations, thereby supporting long-term diabetes management. Patients using Trivolib 1 Tablet can expect a reduction in the overall pill burden compared to taking separate medications, making it a convenient choice for those seeking effective diabetes control. In summary, Trivolib 1 Tablet is an essential medication for individuals with type 2 diabetes, offering a multifaceted approach to managing blood sugar levels and improving overall health outcomes.

Uses & Benefits

  • Trivolib 1 Tablet effectively targets multiple pathways involved in glucose metabolism.
  • This formulation improves both fasting and post-meal sugar levels.
  • Trivolib 1 Tablet helps reduce glucose fluctuations throughout the day.
  • Convenient combination therapy reduces the number of pills needed compared to separate medications.
  • Supports long-term diabetes management by improving HbA1c levels when used regularly.
  • Addresses inadequate insulin secretion, insulin resistance, and excessive post-meal glucose absorption.
  • Trivolib 1 Tablet is particularly beneficial for patients requiring intensified therapy for progressive type 2 diabetes.
  • Helps maintain stable daily blood sugar patterns for better overall health.
How Trivolib 1 Tablet works

Trivolib 1 Tablet works through a combination of three antidiabetic agents: Glimepiride, Metformin, and Voglibose. Each component plays a distinct role in controlling blood sugar levels.


  • Glimepiride stimulates insulin secretion from the pancreas, lowering blood glucose levels effectively.
  • Metformin reduces glucose production in the liver and enhances insulin sensitivity in muscle tissues.
  • Voglibose inhibits carbohydrate breakdown in the intestines, delaying glucose absorption after meals.
  • This combination addresses three major contributors to hyperglycemia: inadequate insulin secretion, insulin resistance, and excessive post-meal glucose absorption.
  • Trivolib 1 Tablet provides a comprehensive approach to managing type 2 diabetes when single or dual therapy is insufficient.
How to use Trivolib 1 Tablet

  • Take Trivolib 1 Tablet exactly as prescribed by your healthcare provider.
  • This medication is usually taken with meals to minimize gastrointestinal discomfort.
  • Swallow the tablet whole with a glass of water; do not crush or chew it.
  • Avoid skipping meals while on Trivolib 1 Tablet to maintain stable blood sugar levels.
  • Regular meal timing is essential for optimal effectiveness of the medication.
  • Monitor your blood sugar levels regularly to assess the effectiveness of Trivolib 1 Tablet.
  • The dosage may vary based on individual blood glucose levels and clinical response; consult your doctor for adjustments.
  • Duration of treatment should be determined by your healthcare provider based on your specific needs and response to therapy.
Lifestyle Advice

  • Avoid skipping meals to maintain stable blood sugar levels while using Trivolib 1 Tablet.
  • Carry a source of glucose for immediate relief in case of hypoglycemia.
  • Regularly monitor HbA1c levels to assess long-term diabetes management effectiveness.
  • Maintain a balanced diabetic diet and engage in regular physical activity for optimal results.
  • Attend regular medical follow-ups to adjust treatment as necessary based on your condition.

Side Effects

  • Common side effects of Trivolib 1 Tablet include hypoglycemia, especially if meals are delayed or missed.
  • Mild abdominal discomfort may occur during the initial stages of treatment.
  • Flatulence is common due to delayed carbohydrate digestion caused by Voglibose.
  • Nausea may be experienced but often improves as the body adjusts to the medication.
  • Diarrhea is frequently associated with Metformin during early treatment phases.
  • Serious side effects requiring immediate medical attention include severe hypoglycemia and lactic acidosis.
  • Persistent nausea or jaundice may indicate liver dysfunction and should be reported to a doctor promptly.

Precautions and Warnings

  • Trivolib 1 Tablet should not be used by individuals with known allergies to any of its components.
  • Avoid use in patients with moderate to severe kidney disease or metabolic acidosis.
  • Caution is advised when consuming alcohol as it increases the risk of hypoglycemia and lactic acidosis.
  • Pregnant women should consult their doctor before using Trivolib 1 Tablet due to potential risks to the developing fetus.
  • Breastfeeding mothers should seek medical advice before using this medication as it may pass into breast milk.
  • Driving may be affected if blood sugar levels are too low or too high; caution is advised.
  • Regular monitoring of liver function is recommended during treatment with Trivolib 1 Tablet.
1. What is Trivolib 1 Tablet used for?
Trivolib 1 Tablet is utilized for managing type 2 diabetes mellitus when blood sugar levels are not adequately controlled with fewer medications.
It aids in improving both fasting and post-meal glucose levels through its unique combination of active ingredients.
2. Why are three medicines combined in one tablet?
The combination of Glimepiride, Metformin, and Voglibose in Trivolib 1 Tablet allows for improved glucose control by addressing different mechanisms: enhancing insulin secretion, reducing liver glucose production, and delaying carbohydrate absorption.
3. Can Trivolib 1 Tablet cause hypoglycemia?
Yes, Trivolib 1 Tablet can lead to hypoglycemia due to its Glimepiride component.
Symptoms may include dizziness, sweating, and confusion, particularly if meals are missed or delayed.
4. Should Trivolib 1 Tablet be taken with food?
Yes, it is recommended to take Trivolib 1 Tablet with meals to minimize gastrointestinal discomfort and enhance its effectiveness in controlling post-meal glucose levels.
5. Does Voglibose reduce post-meal blood sugar?
Yes, Voglibose within Trivolib 1 Tablet works by inhibiting carbohydrate digestion in the intestine, which helps lower the rise in blood glucose after meals.
6. Is Trivolib 1 Tablet safe for long-term use?
Trivolib 1 Tablet is generally considered safe for long-term use under regular medical supervision and monitoring of blood sugar levels.
7. Can alcohol be consumed while taking Trivolib 1 Tablet?
Alcohol consumption should be limited while using Trivolib 1 Tablet as it can increase the risk of hypoglycemia and lactic acidosis.

Directions for Use

Use only as prescribed by your physician.

Storage and Disposal

Please refer to the product label for storage information.
SKU 296078
Country of Manufacture India
Manufacturer Address Sun Pharmaceutical Industries Ltd
Return/Buy Back policy Non-returnable
Prescription Required Yes
Storage Please refer to the product label for storage information.
Seller Kogland Commerce Pvt Ltd (TN)

Door Step Delivery

Quick and Secure

No Hidden Charges

Pay only what's shown

18K Pincodes Served

With Trust & Reliability

Customer Reviews

No reviews yet

Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.

Write Your Own Review

Only registered users can write reviews. Please Sign in or create an account

Please wait…

Share Your Requirements With Us

Please fill out the form below. We'll get back to you. Thank you for your patience.